Skip to content

Life Sciences

OOS and OOT: two results, two different triggers

  • Life Sciences
  • 1 min read

One water result reads 1.4 µS/cm against a site specification of 1.3 and is investigated. Another reads 1.1 and is filed as a pass.

For a year that second sampling point had read between 0.6 and 0.7. The 1.1 is inside the specification and far outside the pattern, and it may say more about the loop than the 1.4 does.

The first result is OOS, out of specification. The FDA guidance on investigating OOS results (2022) uses the term for any test result that falls outside the specifications or acceptance criteria, and says the first phase of the investigation should include an assessment of the accuracy of the laboratory's data, where possible before the test preparations are discarded.

The second is OOT, out of trend. Neither that guidance nor EU GMP defines the term. In common use it is a result within the limits that does not fit what earlier results lead you to expect. EU GMP Chapter 6 says some kinds of data should be recorded in a manner permitting trend evaluation, and any out of trend or out of specification data should be addressed and subject to investigation.

Catching the 1.1 takes a trend chart for that point and a rule for a break, written down before the data arrives.

Industries

Related

More on this subject

Taking over a facility: start with a written gap assessment

Before changing an inherited facility or design, a written gap assessment against the URS and target regulations gives management and inspectors the same picture: evidence from documents and spot measurements, findings graded by risk, and the fix, cost range and schedule impact of each, plus what can stay.

InsightRead

10–15 Pa for FDA, 10 Pa for Annex 1: one cascade

FDA's 2004 aseptic guidance asks for at least 10–15 Pa between rooms of different classification; Annex 1 gives at least 10 Pa as guidance. Setting each cascade step at 15 Pa meets both. Holding it is harder: seals wear and filters load, so trend the differentials instead of waiting for alarms.

InsightRead

Tabulating twenty or thirty past batches was once called retrospective validation. The 2015 text of EU GMP Annex 15 (section 5) says it is no longer an acceptable approach: a traditional process should undergo prospective validation, with concurrent validation only in exceptional circumstances. The batch history belongs in ongoing process verification.

InsightRead